# Correction: Safety and efficacy of nemolizumab for patients with pruritus: a systematic review and meta-regression analysis of randomized controlled trial

**Authors:** Junqin Liang, Fengxia Hu, Maoli Dan, Yingbing Sang, Kailibinuer Abulikemu, Qian Wang, Yongzhen Hong, Xiaojing Kang

PMC · DOI: 10.3389/fimmu.2026.1773876 · Frontiers in Immunology · 2026-02-03

## Full-text entities

- **Diseases:** AD (MESH:D000544), Dermatitis (MESH:D003872), Pruritus (MESH:D011537), prurigo nodularis (MESH:D011536), atopic dermatitis (MESH:D003876)
- **Chemicals:** Nemolizumab (MESH:C000612881)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12910468/full.md

---
Source: https://tomesphere.com/paper/PMC12910468